tradingkey.logo
搜索

aTyr Pharma Inc

ATYR
添加自选
0.486USD
+0.006+1.19%
收盘 07-31 16:00美东报价延迟15分钟
47.59M总市值
亏损市盈率 TTM

ATYR 财务数据

通过专为投资者打造的一站式数据看板,全面查看 aTyr Pharma Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图,助您更轻松地进行财务分析。您可以查看最新年度财务报告,也可以通过利润表、资产负债表和现金流量表,按季度分析公司表现。借助实时财务指标,持续追踪公司的经营状况和市场表现更加便捷。

aTyr Pharma Inc财报日历

最新发布
5月 15, 2026
每股收益 / 预测值
-0.11/-0.14
营业收入 / 预测值
--/0.00
报告期
FY2025 财报
营业收入(YoY)
190.00K
-19.15%
每股收益(YoY)
-0.80
7.54%
分析师评级
BUY
2026/08/01
单季报
单季报+年报
单季报
年报
YOY
隐藏空白行
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
财务指标
每股收益
36.03%-0.11
21.25%-0.14
-16.38%-0.26
3.93%-0.22
26.61%-0.17
27.34%-0.18
-16.23%-0.23
-0.82%-0.23
17.81%-0.23
3.65%-0.25
---0.20
---0.22
---0.29
---0.26
---1.34
----
----
----
----
----
营业收入
----
--0.00
--190.00K
--0.00
-100.00%0.00
--0.00
-100.00%0.00
--0.00
--235.00K
-100.00%0.00
--353.00K
----
----
--10.39M
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
净利润
27.48%-10.79M
6.71%-13.96M
-49.16%-25.74M
-19.78%-19.53M
3.94%-14.88M
-1.40%-14.97M
-52.20%-17.26M
-32.16%-16.31M
-29.62%-15.49M
-96.25%-14.76M
14.38%-11.34M
0.66%-12.34M
1.66%-11.95M
12.13%-7.52M
-72.74%-13.24M
-19.53%-12.42M
-69.95%-12.15M
-73.54%-8.56M
-16.18%-7.67M
-61.20%-10.39M
利润率
----
----
---13550.53%
----
----
----
----
----
---6590.21%
----
---3213.03%
----
----
---72.43%
----
----
----
----
----
----
毛利率
----
----
--100.00%
----
----
----
----
----
--100.00%
----
--100.00%
----
----
--100.00%
----
----
----
----
----
----
资产负债率
-29.69%0.94%
-35.18%0.96%
-43.25%0.96%
-27.75%1.15%
-16.27%1.33%
-7.57%1.47%
12.03%1.70%
7.03%1.59%
9.53%1.59%
20.24%1.60%
--1.52%
--1.48%
--1.45%
--1.33%
--0.81%
----
----
----
----
----
营业收入
----
--0.00
--190.00K
--0.00
-100.00%0.00
--0.00
-100.00%0.00
--0.00
--235.00K
-100.00%0.00
--353.00K
----
----
--10.39M
----
----
----
-100.00%0.00
-100.00%0.00
-100.00%0.00
营业利润
27.50%-11.44M
6.47%-14.80M
-47.41%-26.75M
-17.31%-20.31M
5.19%-15.77M
0.87%-15.82M
-43.82%-18.14M
-27.71%-17.32M
-30.10%-16.64M
-100.74%-15.96M
6.50%-12.62M
-7.74%-13.56M
-3.30%-12.79M
7.99%-7.95M
-74.59%-13.49M
-20.48%-12.58M
-71.87%-12.38M
-74.90%-8.64M
-18.67%-7.73M
-65.32%-10.45M
净利润
27.48%-10.79M
6.71%-13.96M
-49.16%-25.74M
-19.78%-19.53M
3.94%-14.88M
-1.40%-14.97M
-52.20%-17.26M
-32.16%-16.31M
-29.62%-15.49M
-96.25%-14.76M
14.38%-11.34M
0.66%-12.34M
1.66%-11.95M
12.13%-7.52M
-72.74%-13.24M
-19.53%-12.42M
-69.95%-12.15M
-73.54%-8.56M
-16.18%-7.67M
-61.20%-10.39M
流动资产
-18.85%67.58M
-2.10%80.24M
21.88%93.01M
-3.11%87.49M
-14.08%83.27M
-20.43%81.95M
-28.87%76.32M
-21.09%90.30M
-18.86%96.92M
27.35%102.99M
26.78%107.30M
22.58%114.43M
15.84%119.45M
-28.79%80.87M
-30.38%84.63M
101.17%93.36M
97.79%103.12M
219.63%113.57M
218.10%121.57M
5.86%46.41M
流动负债总额
9.51%11.70M
1.21%15.15M
11.05%15.68M
31.21%15.53M
-33.14%10.68M
-8.83%14.97M
9.60%14.12M
-4.29%11.84M
17.03%15.98M
18.42%16.42M
14.88%12.88M
33.56%12.37M
117.80%13.65M
130.53%13.86M
92.66%11.21M
27.13%9.26M
40.84%6.27M
2.54%6.01M
-27.55%5.82M
-25.67%7.28M
总资产
-18.09%79.65M
-3.95%93.00M
16.41%106.65M
-4.16%101.53M
-14.13%97.25M
-19.75%96.83M
-26.75%91.62M
-20.19%105.94M
-17.24%113.25M
25.96%120.65M
30.21%125.07M
38.26%132.75M
30.60%136.84M
-17.09%95.79M
-22.48%96.06M
95.97%96.02M
90.06%104.78M
198.34%115.54M
197.62%123.92M
3.01%48.99M
总负债
-2.10%21.91M
-4.75%25.71M
0.49%26.61M
9.64%26.88M
-22.73%22.38M
-10.55%27.00M
-1.45%26.48M
-8.17%24.52M
6.74%28.97M
23.19%30.18M
41.04%26.87M
179.29%26.70M
323.93%27.14M
282.19%24.50M
194.10%19.05M
16.70%9.56M
14.40%6.40M
-11.47%6.41M
-32.80%6.48M
-29.54%8.19M
总权益
-22.87%57.74M
-3.64%67.29M
22.88%80.04M
-8.31%74.66M
-11.18%74.86M
-22.81%69.83M
-33.67%65.14M
-23.22%81.42M
-23.17%84.28M
26.91%90.47M
27.53%98.20M
22.66%106.05M
11.51%109.70M
-34.68%71.28M
-34.43%77.01M
111.88%86.46M
98.61%98.37M
246.61%109.13M
267.02%117.44M
13.54%40.80M
经营净额
18.83%-12.52M
7.13%-12.20M
-55.62%-20.48M
32.06%-13.89M
31.10%-15.42M
-18.71%-13.13M
-37.65%-13.16M
-70.27%-20.45M
-3693.22%-22.38M
-6.68%-11.06M
22.16%-9.56M
-31.73%-12.01M
94.17%-590.00K
-28.23%-10.37M
-7.07%-12.28M
-18.53%-9.12M
-73.66%-10.12M
-49.71%-8.09M
-106.48%-11.47M
-20.13%-7.69M
投资净额
360.05%11.49M
370.22%16.44M
-213.55%-20.38M
-50.94%3.30M
-225.96%-4.42M
-134.15%-6.08M
309.45%17.95M
261.89%6.73M
96.45%-1.36M
791.35%17.82M
-78.77%4.38M
-141.68%-4.16M
-360.99%-38.17M
104.05%2.00M
239.06%20.65M
350.91%9.97M
162.52%14.63M
-1640.68%-49.35M
-953.39%-14.85M
57.94%-3.97M
融资净额
-100.76%-142.00K
-100.70%-131.00K
28306.67%29.62M
33.56%17.90M
140.98%18.63M
212.21%18.84M
-103.91%-105.00K
67.12%13.40M
-84.38%7.73M
557.30%6.03M
-10.99%2.68M
20458.97%8.02M
3242.07%49.50M
3178.57%918.00K
-96.41%3.01M
-96.93%39.00K
-94.04%1.48M
-97.20%28.00K
25010.48%83.87M
164.55%1.27M

常见问题

aTyr Pharma Inc的总收入是多少?

根据aTyr Pharma Inc的FY2025财报,总收入达到了190.00K(同比变化235.00K)。

aTyr Pharma Inc的流动资产是多少?

根据aTyr Pharma Inc的FY2025财报,流动资产为80.24M(同比变化-2.10)。

aTyr Pharma Inc的总资产是多少?

根据aTyr Pharma Inc的FY2025财报,aTyr Pharma Inc的总资产为93.00M(同比变化-3.95)。

aTyr Pharma Inc的总负债是多少?

根据aTyr Pharma Inc的FY2025财报,aTyr Pharma Inc的总负债为25.71M(同比变化-4.75)。

aTyr Pharma Inc的总权益是多少?

根据aTyr Pharma Inc的FY2025财报,aTyr Pharma Inc的总权益为67.29M(同比变化-3.64)。

aTyr Pharma Inc的净营业收入是多少?

根据aTyr Pharma Inc的FY2025财报,aTyr Pharma Inc的净营业收入为-77.63M(同比变化-14.30)。

aTyr Pharma Inc的净投资是多少?

根据aTyr Pharma Inc的FY2025财报,aTyr Pharma Inc的净投资为-5.05M(同比变化-129.32)。

aTyr Pharma Inc的净融资是多少?

根据aTyr Pharma Inc的FY2025财报,aTyr Pharma Inc的净融资为66.01M(同比变化65.59)。

aTyr Pharma Inc的每股收益(EPS)是多少?

根据aTyr Pharma Inc的FY2025财报,每股收益(EPS)为-0.80(同比变化7.54)。

aTyr Pharma Inc的净利润是多少?

根据aTyr Pharma Inc的FY2025财报,净利润为-74.12M(同比变化-15.77)。

aTyr Pharma Inc的净利润率是多少?

根据aTyr Pharma Inc的FY2025财报,净利润率为-39012.11(同比变化-43.20)。

aTyr Pharma Inc的债务与资产比率是多少?

根据aTyr Pharma Inc的FY2025财报,债务与资产比率为0.96(同比变化-35.18)。

aTyr Pharma Inc的股东权益回报率(ROE)是多少?

根据aTyr Pharma Inc的FY2025财报,股东权益回报率(ROE)为-107.81(同比变化-35.28)。

aTyr Pharma Inc的资产回报率(ROA)是多少?

根据aTyr Pharma Inc的FY2025财报,资产回报率(ROA)为-78.09(同比变化-32.64)。

aTyr Pharma Inc的营业利润是多少?

根据aTyr Pharma Inc的FY2025财报,营业利润为-77.63M(同比变化-14.30)。
tradingkey.logo
风险提示:我们的网站和移动应用程序仅提供关于某些投资产品的一般信息。Finsights 不提供财务建议或对任何投资产品的推荐,且提供此类信息不应被解释为 Finsights 提供财务建议或推荐。
投资产品存在重大投资风险,包括可能损失投资的本金,且可能并不适合所有人。投资产品的过去表现并不代表其未来表现。
Finsights 可能允许第三方广告商或关联公司在我们的网站或移动应用程序的任何部分放置或投放广告,并可能根据您与广告的互动情况获得报酬。
© 版权所有: FINSIGHTS MEDIA PTE. LTD. 版权所有